AIM ImmunoTech (AIM) Earnings Date & Reports

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AIM is expected to report earnings to fall 10.00% to -9 cents per share on May 15

AIM ImmunoTech AIM Stock Earnings Reports

Q1'25

Est.

$-0.09

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.09

Q1'24

Est.

$-0.12

The last earnings report on March 27 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 8.59K shares outstanding, the current market capitalization sits at 7.07M.

View a ticker or compare two or three

Compare

AIM